Author:
Boutan-Laroze A.,Mahjoubi M.,Droz J.P.,Charrot P.,Fargeot P.,Kerbrat P.,Caty A.,Voisin P.M.,Spielmann M.,Rey A.,Giraud B.
Reference17 articles.
1. Edtimation de l'incidence des cancers en France Bull.;Laplanche;Cancer (Paris),1991
2. Phase II trial of cyclophosphamide, doxorubicin and cisplatin (CAP) versus amsacrin in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group Study;Al-Sarraf;Cancer Treat Rep,1985
3. Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group Study;Harker;J Clin Oncol,1985
4. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the MD Anderson Experience;Logothetis;J Urol,1989
5. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J Urol,1985
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献